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Summary The covalent binding of a carotene moiety to one phenyl ring and meso-tetraphenyl-substituted
porphyrins (see Figure 1) efficiently quenches the photosensitising activity of the porphyrin while a relatively
large yield of fluorescence emission around 650 nm is retained. Pharmacokinetic studies performed with two
carotenoporphyrins (CPs) and the corresponding porphyrins (Ps) in Balb/c mice bearing an MS-2 fibrosar-
coma show that the two Ps give a high selectivity of tumour localisation (tumour/peritumoral tissue ratios of
dye concentration ranging between c. 30 and 90 at 24 h after injection of 4.2-8.4 1tmol kg- in a Cremophor
emulsion) and photosensitise tumour necrosis upon red light irradiation. For the same injected doses, the two
CPs show no tumour-photosensitising activity even though they localise in the tumour in concentrations of the
order of 10-40 jug g-' at 24 h with tumour/peritumoral ratios larger than 10. Thus, the fluorescence emitted
by these CPs in the tumour can be used for photodiagnostic purposes with no risk of skin photosensitisation.
However, this approach is presently limited by the large accumulation and prolonged retention of the CPs in
the liver and spleen.
The observation that some porphyrins and their analogues
are accumulated in significant amounts and retained for pro-
longed periods of time by a variety of solid tumours (Zhou,
1989; Marcus, 1992) has opened new prospects for the
therapy of neoplastic lesions by taking advantage of the
photosensitising properties of many tetrapyrrolic compounds
(Jori & Spikes, 1984), as well as for the early diagnosis of
such lesions based on the fluorescence emission typical of the
porphyrin chromophore (Profio & Balchum, 1985; Unsold et
al., 1990). The latter application is presently limited by two
main factors: (i) the degree of selectivity of tumour labelling
by the porphyrin is limited, because the ratio of photosen-
sitiser concentration in the tumour to the peritumoral tissue
often does not exceed 2-3:1 (Jori, 1990); and (ii) the per-
sistence of appreciable levels of photosensitivity in several
tissues, including skin, for several weeks after systemic
administration of the porphyrin (Dougherty, 1987).
Therefore, the development of safe and reliable photodiag-
nostic procedures requires the availability of highly fluores-
cent selective tumour localisers which are devoid of any
appreciable photosensitising activity.
In this paper, we demonstrate the use of carotenopor-
phyrins (see Figure 1) as tumour-specific photodiagnostic
agents. These compounds possess absorption spectra which
essentially represent the sum of typical spectra of unlinked
meso-substituted porphyrins and carotenes (Dirks et al.,
1980). The two-banded fluorescence spectrum (peaks at 655
and 720 nm) is again typical of porphyrins, with little or no
contribution from the carotene. The covalent attachment of
the carotene moiety to the porphyrin macrocycle through
properly selected linkers ensures an electronic interaction
between the i systems of the two chromophores, leading to
an efficient quenching of the porphyrin triplet state by an
energy transfer process. The porphyrin triplet state is the
most reactive intermediate in porphyrin-photosensitised pro-
cesses (Moore et al., 1982; Gust et al., 1992a). The generation
of singlet molecular oxygen ('02), which is a highly cytotoxic
species, is an important reaction arising from the porphyrin
triplet state. Moreover, via the energy transfer process:
'02 + Car-302 + 3Car, carotenoids could deactivate any
singlet oxygen which may have escaped carotene quenching
(Cogdell & Frank, 1987). On the other hand, structural and
energetic factors preclude the efficient carotene quenching of
the porphyrin first excited singlet state, from which
fluorescence originates (Gust et al., 1992a).
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Thus, carotenoporphyrins possess unique photophysical
and spectroscopic properties which make these compounds
potentially suitable as in vivo diagnostic agents.
Materials and methods
Chemicals
The porphyrins and carotenoporphyrins were synthesised at
Arizona State University following procedures previously
described (Gust et al., 1992b). The tetraarylporphyrins were
prepared by the classic method of Adler-Rothemund. The
desired carotenoic acid was synthesised from 8'-apo-p-
carotenal by a Wittig reaction with 4-carbomethoxybenzyl-
triphetylphosphonium bromide using sodium methoxide as
the base, followed by basic hydrolysis. The coupling of the
chromophores through the amide linkage was accomplished
by forming the acid chloride of the carotenoic acid, by
treatment of the acid with thionyl chloride, and the
immediate reaction of it with the appropriate amino-
substituted tetraarylporphyrin. Cremophor-EL was supplied
by Sigma. All other chemicals and solvents were analytical-
grade reagents.
Animals and tumour
Female Balb/c mice (18-22 g body weight) were supplied by
Charles River (Como, Italy) and kept in cages with free
access to tap water and standard dietary chow. Animal care
was performed according to the guidelines established by the
Italian Committee for Experimental Animals.
The MS-2 fibrosarcoma was originally supplied by the
Istituto Nazionale dei Tumori (Milan, Italy). The tumour
was transplanted into the right hindleg of the mice by injec-
tion of 0.2 ml of a cell suspension containing 106cells ml'.
The experiments were performed 7-8 days after tumour
implantation when the external tumour diameter was about
0.7 cm. When necessary, the mice were anaesthetised by i.p.
injection of Ketalar (150 mg kg-').
Preparation ofthe Cremophor emulsion
Because of their hydrophobic nature, the porphyrins and
carotenoporphyrins were dispersed in a Cremophor-EL emul-
sion before administration to the animals. We used a
modification of the procedure originally described by Mor-
gan et al. (1987). Typically, 3.3 mg of porphyrin or 5 mg of
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Figure 1 Chemical structures of the porphyrins and carotenoporphyrins used in the present investigation.
carotenoporphyrin was added to 0.5 ml of Cremophor and
sonicated until the porphyrin was completely dispersed in the
emulsifier agent. The suspension was added to 0.15 ml of
absolute ethanol, sonicated again and taken to a final volume
of 10 ml by the stepwise addition of a saline solution at
pH 7.4. The porphyrin and carotenoporphyrin concentrations
in the emulsion were measured by absorption spectroscopy
using an extinction coefficient of 3.74 x I0 M1cm'- at
420 nm.
Pharmacokinetic studies
Both normal and tumour-bearing mice were i.v. injected with
a porphyrin or carotenoporphyrin dose of 4.2 or 8.4ILmol
kg-', corresponding to about 0.2 or 0.4 ml of Cremophor
emulsion respectively. The tumour-bearing mice were sac-
rificed at time intervals between 3 h and 1 week after injec-
tion, while the normal mice were sacrificed at time intervals
between and 4 weeks. The sera as well as several tissues,
including the tumour, were collected from the mice, washed
with saline solution and homogenised in 2% sodium dodecyl
sulphate (SDS) for the analysis of their porphyrin or
carotenoporphyrin content. An aliquot of the homogenate
was diluted 1:30 with a mixture of methanol-chloroform
(2:1, v/v) and centrifuged for 10 min at 3,000 r.p.m. The
supernatant was analysed spectrophotofluorimetrically with a
Perkin-Elmer MPF4 instrument. The sera were analysed
directly after dilution with 2% SDS. The samples were
excited with 420 nm light and the fluorescence emission of
the porphyrin was monitored in the 550-720 nm range. The
intensities of the two emission maxima were measured and
the porphyrin concentration was calculated by interpolation
with a calibration plot.
High-performance liquid chromatography (HPLC) analyses
Samples of porphyrin and carotenoporphyrin were analysed
by normal-phase HPLC. Typcially, CP(Me)3 and the corres-
ponding porphyrin P(Me)3 were dissolved in dichloromethane
and eluted with dichloromethane through a silica gel column
at a flow rate of 0.5 ml min i, using a Perkin-Elmer, Series 4,
HPLC apparatus. The eluate was monitored at 420 nm, the
absorption maximum of CP(Me)3 and P(Me)3. Liver and
tumour extracts in chloroform-methanol, obtained from
mice at 24 h after injection of CP(Me)3 (4.2 gimol kg-'), were
taken to dryness by a rotary evaporator, resuspended in
dichloromethane (1 ml), and eluted through the HPLC col-
umn in an analogous manner.
Photosensitisation studies
Tumour-bearing mice were injected with 8.4 or 16.8 ,mol
kg-1 P(Me)3 or CP(Me)3, and after 24 h the tumour area was
irradiated with red light (600-700 nm) isolated by optical
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filters from the emission of a 250 W halogen lamp, equipped
with a bundle of optical fibres (external diameter 0.6cm).
The light was delivered at a dose rate of 200 mW cm-2 for a
total light dose of 450 J cm-2. At 24 h after irradiation the
tumour was removed and the extent of the necrotic area was
measured following the procedure described by Reddi et al.
(1990). The treated tumours were compared with control
tumours that received only light and with controls that were
not treated at all.
Serum protein distribution ofcarotenoporphyrins
The distribution of CP(Me)3 among the mouse serum pro-
teins was studied at 3 and 24 h after the injection of
4.2 limol kg-'. The serum protein separation was performed
by density-gradient ultracentrifugation of the serum follow-
ing the procedure reported by Terpstra et al. (1981).
Typically, 2 ml of serum was added with potassium bromide
(0.77 g) and sucrose (0.05 g) and placed in a centrifuge tube.
Subsequently, the serum, at d = 1.25 gml-', was overlayered
with 2ml of a salt solution of d= 1.225gml-' (11.42mg
ml-' sodium chloride and 315.54mgml1' potassium bro-
mide), 4ml of a salt solution of d= 1.10gml (11.42mg
ml-' sodium chloride and 133.48 mg ml-l potassium bro-
mide) and 3 ml of distilled water. For each sample of serum,
a tube containing 2 ml of serum prestained with Sudan black
was centrifuged and used as a control for lipoprotein
visualisation in the density gradient. The tubes were placed in
a SW-41 swinging-bucket rotor (Beckman) and centrifuged
for 24 h at 39,000 r.p.m. in an Ultra Centrikon T-2060 ultra-
centrifuge. After centrifugation, the lipoprotein fractions
were isolated using as reference the stained lipoprotein bands
of the corresponding tube containing Sudan black. The frac-
tions, sequentially isolated from the top of the tube, con-
tained very low-density lipoproteins (VLDL, fraction 1),
Cremophor* with unbound CP(Me)3 (fraction 2), low-density
lipoproteins (LDL, fraction 3), high-density lipoproteins
(HDL, fraction 4) and heavy proteins, including albumin and
globulins (fraction 5). The volume of each fraction was
measured, and after dialysis against a 0.9% sodium chloride
solution and dilution in 2% SDS the fractions were analysed
spectrophotofluorimetrically to determine the amount of
associated CP(Me)3.
Results
Pharmacokinetic studies
The analysis of the sera taken from mice at different times
after the administration of CP(Me)3 or CP(OMe)3 showed
that both carotenoporphyrins are cleared from the blood-
stream in about 1 week (see Figure 2). After this time inter-
val, only traces ofcarotenoporphyrin could be detected in the
serum samples.
The fractionation of the serum proteins at 3 and 24 h after
the administration of 4.2 imol kg-' CP(Me)3 showed that
this carotenoporphyrin is almost exclusively bound to lipo-
proteins (Table I). Only negligible amounts of carotenopor-
phyrin were recovered from fraction 5, which includes
albumin and globulins. However, the delivery of the
carotenoporphyrin from Cremophor micelles to serum pro-
teins appears to be a slow process. As can be seen in Table I,
at 3 h after administration, c. 76% of CP(Me)3 is still
retained in the Cremophor micelles.
*The identification of fraction 2 as Cremophor is based on the
following considerations: (i) the fraction is not observed in sera
obtained from animals not injected with Cremophor; (ii) the intensity
of the band strongly decreases between 3 h and 24 h after injection in
correspondence with the clearance of Cremophor from serum; and
(iii) the fraction is not stained by Sudan black, which readily stains
lipoproteins. The last finding rules out the possibility that fraction 2
contains some lipoproteins with a modifed density owing to interac-
tion with Cremophor.
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Figure 2 Concentrations of carotenoporphyrins in the serum of
Balb/c mice as a function of time after administration. The mice
were injected with CP(OMe)3 doses of 4.2 (-) and 8.4tLmol kg-'
(@) or with a CP(Me)3 dose of 4.2 gLmol kg'- (A).
Table I Distribution of CP(Me)3 among the various serum protein
classes at 3 and 24 h after the injection of 4.2 gimol kg-'
Recovery
3h 24h
Fraction ,iga % 1Iga %
1 (VLDL) 1.92 1.10 0.08 0.70
2 Cremophor 129.78 76.00 1.32 11.80
3 (LDL) 10.34 6.00 1.15 10.30
4 (HDL) 28.00 16.40 8.60 77.20
5 (heavy proteins) 0.81 0.50 traces
alig ofCP(Me)3 bound to the protein fractions isolated from 2 ml of
serum.
The time dependency of CP(OMe)3 biodistribution in
selected tissues of mice bearing the MS-2 fibrosarcoma is
shown in Figure 3a and b for dye doses of 4.2 and
8.4 tLmol kg-' respectively. In both cases, the largest amounts
of carotenoporphyrins were recovered from liver and spleen,
as is typical of several hydrophobic porphyrin derivatives
that are eliminated from the organism largely by the bile-gut
pathway (Jori, 1987). Amounts of CP(OMe)3 smaller than
those found in liver and spleen were accumulated by tumour
tissue, especially at the lower carotenoporphyrin dose. The
maximal recoveries of CP(OMe)3 from the tumour were
found at 24 h after administration and were found to be 8.7
and 38 glgg-' for the injected doses of 4.2 and 8.4 lmolkg-'
respectively. Consistently low (<2fig g-1) amounts of
CP(OMe)3 were found in skin and muscle at all time inter-
vals. The pharmacokinetic behaviour of CP(Me)3 and the
two parent porphyrins P(OMe)3 and P(Me)3 was very similar
to that observed for CP(OMe)3. In Figure 4 we show the
recoveries of P(OMe)3 from various tissues after admin-
istration of 4.2pmol kg-1. Once again, large amounts of
porphyrin were recovered from the components of the
reticuloendothelial system, while maximal porphyrin accum-
ulation in the tumour (c. 10.41ggg-1) occurred at 24h after
administration; moreover, low amounts of the porphyrin
were found in muscle and skin. The ratio of dye concentra-
tion in the tumour to that in the muscle at 24 h after
injection is shown in Table II for CP(OMe)3, CP(Me)3, P(OMe)3 and P(Me)3; this parameter represents an index of
the selectivity of tumour targeting because the muscle is the
peritumoral tissue in our animal model. Table II also shows
the 24 h value for the tumour/skin ratio of dye concentra-
tion.
The pharmacokinetic studies performed with healthy Balb/c
mice showed a long-term persistence of the carotenopor-
phyrins and porphyrins in the liver and spleen. As shown in
Table III, significantly high amounts of P(OMe)3 and, to an
even greater extent, of CP(OMe)3 are still present in both
tissues 4-8 weeks after injection of 4.2 gmol kg-'. The dyePHOTODIAGNOSIS OF TUMOURS 43
Table II Ratio between the concentration of the porphyrins and
carotenoporphyrins inthetumourandthemuscleandinthetumourand
the skin at 24 h after administration
Injected dose
Drug (pmolkg-) Tumour/muscle Tumour/skin
CP(OMe)3 4.2 27 7
CP(OMe)3 8.4 32 24
CP(Me)3 4.2 12 7
CP(Me)3 8.4 11 5
P(OMe)3 4.2 94 29
P(Me)3 8.4 33 9
TableIII Recoveries, expressed asItgpergoftissue, ofCP(OMe)3 and
P(OMe)3 from theliverandspleenofhealthymiceatseveralweeksafter
the administration of4.2JLmol kg-'
Time Liver
(weeks) CP(OMe)3 P(OMe)3
1 86± 2.5 n.d. 47± 13.1 n.d.
2 93±8.9 18± 1.6 33±3.8 19±3.2
4 78 ± 3.3 26± 2.9 42 ± 13.2 10 ± 2.8
8 86± 3.7 n.d. 37± 9.0 n.d.
n.d., not determined.
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Figure 3 Time dependence of CP(OMe)3 distribution in selected
tissues of Balb/c mice bearing a MS-2 fibrosarcoma injected with
a, 4.2 or b, 8.4 tmol kg-'.
24 48
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Figure 4 Time dependence of P(OMe)3 distribution in selected
tissues of Balb/c mice bearing a MS-2 fibrosarcoma injected with
4.2 tLmol kg-'.
concentration does not undergo any appreciable decrease
with time, especially from the liver.
Selected liver extracts which contained appreciable concen-
trations of carotenoporphyrins were analysed by absorption
spectroscopy in the visible spectral region: the position of the
absorption bands characteristic of the carotene and por-
phyrin moieties were essentially identical to those typical of a
carotenoporphyrin in a 2:1 methanol-chloroform solution.
The high-performance liquid chromatogram of liver and
tumour extracts from mice injected with CP(Me)3 showed a
single component absorbing at 420 nm, whose retention time
(t = 6.96 min) was coincident with that found for CP(Me)3;
under the same conditions, P(Me)3 exhibited a retention time
of 11.24 min.
Photosensitisation studies
Tumour-bearing mice were injected with 8.4 or 16.8pmol
kg-' P(Me)3 or CP(Me)3, and after 24 h the tumour was
artwork:
irradiated with red light. The analysis of the tumour tissue
performed at 24 h after irradiation showed the formation of
a necrotic area (21.5 mm2) only in the tumours treated with
P(Me)3. On the contrary, the tumour irradiated in the
presence of CP(Me)3 did not show any necrosis. The tumours
that received only light or were not treated also showed no
necrosis.
Discussion
Our data show that the two meso-substituted porphyrins and
the corresponding carotenoporphyrins studied in the present
investigation are efficient tumour localisers. The phar-
macokinetic behaviour of these compounds is typical of por-
phyrinoids administered in vivo by means of hydrophobic
delivery systems, including the large accumulation in com-
ponents of the reticuloendothelial system, and the relatively
slow increase of dye concentration in the tumour, which
reaches a maximum value c. 24 h after i.v. administration. On
the other hand, some interesting features are the fast elimina-
tion of the carotenoporphyrins from serum, as compared
with the persistence of appreciable amounts of Photofrin in
mouse serum for several weeks (Bellnier et al., 1989), as well
as the notably low amounts of dye which were found in
muscle and skin throughout our observation period.
The low levels of drug in skin should minimise the risk of
general cutaneous photosensitivity induced by P(Me)3 or
P(OMe)3, which are characterised by a good photosensitising
activity (see Gust et al., 1992a, and our tumour photosen-
sitisation studies). Skin photodamage is a well-established
side effect of photodynamic therapy of tumours performed
with Photofrin, which limits the use of this porphyrin as a
photodiagnostic agent (Dougherty, 1987). The rapid clear-
ance of both porphyrins and carotenoporphyrins from serum
further serves to decrease the probability of long-term skin
photosensitivity (Bugelski et al., 1981). Moreover, unusually
large tumour/muscle concentration ratios of porphyrin or
carotenoporphyrin are observed at various time intervals,
and in particular at 24 h after injection (Table II). Such a
high selectivity level appears to be a property of the por-
phyrins (especially the trimethoxy-substituted compounds)
and is independent of the injected dose. This finding is in
agreement with previous observations (Winkelman, 1985;
Bonnett & Berenbaum, 1990) indicating that meso-substitut-
ed porphyrins are excellent tumour localisers. The addition of
the carotene moiety decreases the above-mentioned ratio,
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although the selectivity of tumour targeting remains remark-
ably high. This selectivity may be related to the essentially
complete association of carotenoporphyrins with the lipo-
protein class of serum proteins (Table I). In the lipoprotein
family, LDL has been claimed to play a major role in the
transport and release of photosensitising agents to tumour
cells (Maziere et al., 1990; Jori, 1992). However, this is only a
partial explanation because other porphyrin analogues, such
as phthalocyanines and naphthalocyanines, which are
specifically carried by serum lipoproteins, yield a less pro-
nounced tumour selectivity (Reddi et al., 1990; Cuomo et al.,
1990).
On the whole, carotenoporphyrins CP(Me)3 and CP(OMe)3
display several features which make them very promising
photodiagnostic agents for tumours, including, the high
degree of chemical purity, the efficient fluorescence emission
in the red spectral interval and their marked affinity for
tumours. This prospect obviously needs to be further sup-
ported by extending our studies to tumour models more
closely related to the clinical situation, such as colonic or
oesophageal tumours. The photodiagnostic potential of
carotenoporphyrins is greatly enhanced by their photo-
chemical inertness under conditions where their porphyrin
analogue causes readily detectable photodamage. This lack of
photodynamic activity is certainly a consequence of the
efficient quenching of the porphyrin triplet by the covalently
bound and suitably spaced carotene. Thus, larger amounts of
carotenoporphyrin can be injected, thereby facilitating the
detection of the emitted fluorescence, without any risk of
inducing photosensitising processes. This favourable situation
is unlikely to be modifed by a time-dependent metabolic
alteration of the carotene moiety, which might regenerate the
photosensitising activity of the porphyrin. Our spectroscopic
and HPLC studies of liver extracts seem to rule out any
important change in the chemical structure of the caro-
tenoporphyrins.
One possible drawback of the use ofcarotenoporphyrins in
vivo may be the large amounts of dye which are accumulated
by the liver and are retained for at least 2 months with no
apparent trend toward elimination. In principle, this could
lead to the onset of toxic effects and interference with some
liver functions. A slow rate ofdye release from liver has been
previously observed for the aggregated constitutents of
Photofrin (Bugelski et al., 1981) and some poorly water-
soluble phthalocyanines and naphthalocyanines (Jori &
Reddi, 1991). However, in all these cases, the dye concentra-
tion in the liver gradually diminishes as a function of time,
contrary to what was observed for the carotenoporphyrins.
Recent findings from our laboratory (Cuomo et al., 1991)
suggest a possible correlation between the hydrophobicity of
a dye and the rate of its release from liver; in particular the
release is accelerated by the addition of butoxy substituents
to the phthalocyanine macrocycle. However, in the case of
carotenoporphyrins, the replacement of the methyl groups by
the somewhat more polar methoxy substituents has no ap-
preciable effect on liver clearance. In our opinion, this prob-
lem needs to be adequately addressed if carotenoporphyrins
are to be proposed for tumour photodiagnosis at the clinical
level. Towards this end, we are exploring the effect of
selected manipulation of the porphyrin and carotene struc-
ture.
This work received financial support from Associazione Italiana
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